Literature DB >> 22610095

Engineering an improved IgG4 molecule with reduced disulfide bond heterogeneity and increased Fab domain thermal stability.

Shirley J Peters1, C Mark Smales, Alistair J Henry, Paul E Stephens, Shauna West, David P Humphreys.   

Abstract

The integrity of antibody structure, stability, and biophysical characterization are becoming increasingly important as antibodies receive increasing scrutiny from regulatory authorities. We altered the disulfide bond arrangement of an IgG4 molecule by mutation of the Cys at the N terminus of the heavy chain constant domain 1 (C(H)1) (Kabat position 127) to a Ser and introduction of a Cys at a variety of positions (positions 227-230) at the C terminus of C(H)1. An inter-LC-C(H)1 disulfide bond is thus formed, which mimics the disulfide bond arrangement found in an IgG1 molecule. The antibody species present in the supernatant following transient expression in Chinese hamster ovary cells were analyzed by immunoblot to investigate product homogeneity, and purified product was analyzed by a thermofluor assay to determine thermal stability. We show that the light chain can form an inter-LC-C(H)1 disulfide bond with a Cys when present at several positions on the upper hinge (positions 227-230) and that such engineered disulfide bonds can consequently increase the Fab domain thermal stability between 3 and 6.8 °C. The IgG4 disulfide mutants displaying the greatest increase in Fab thermal stability were also the most homogeneous in terms of disulfide bond arrangement and antibody species present. Importantly, mutations did not affect the affinity for antigen of the resultant molecules. In combination with the previously described S241P mutation, we present an IgG4 molecule with increased Fab thermal stability and reduced product heterogeneity that potentially offers advantages for the production of IgG4 molecules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610095      PMCID: PMC3397877          DOI: 10.1074/jbc.M112.369744

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Contrasting IgG structures reveal extreme asymmetry and flexibility.

Authors:  Erica Ollmann Saphire; Robyn L Stanfield; M D Max Crispin; Paul W H I Parren; Pauline M Rudd; Raymond A Dwek; Dennis R Burton; Ian A Wilson
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

Review 2.  IgG4 breaking the rules.

Authors:  Rob C Aalberse; Janine Schuurman
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

3.  Localisation of the monocyte-binding region on human immunoglobulin G.

Authors:  J M Woof; L J Partridge; R Jefferis; D R Burton
Journal:  Mol Immunol       Date:  1986-03       Impact factor: 4.407

4.  Structural studies of immunoglobulin G.

Authors:  B Frangione; C Milstein; J R Pink
Journal:  Nature       Date:  1969-01-11       Impact factor: 49.962

5.  The binding of human immunoglobulin G1 monomer and small, covalently cross-linked polymers of immunoglobulin G1 to human peripheral blood monocytes and polymorphonuclear leukocytes.

Authors:  R J Kurlander; J Batker
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

6.  The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds.

Authors:  J Schuurman; G J Perdok; A D Gorter; R C Aalberse
Journal:  Mol Immunol       Date:  2001-01       Impact factor: 4.407

7.  Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength.

Authors:  Aran F Labrijn; Theo Rispens; Joyce Meesters; Rebecca J Rose; Tamara H den Bleker; Stefan Loverix; Ewald T J van den Bremer; Joost Neijssen; Tom Vink; Ignace Lasters; Rob C Aalberse; Albert J R Heck; Jan G J van de Winkel; Janine Schuurman; Paul W H I Parren
Journal:  J Immunol       Date:  2011-08-12       Impact factor: 5.422

8.  A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody.

Authors:  S Angal; D J King; M W Bodmer; A Turner; A D Lawson; G Roberts; B Pedley; J R Adair
Journal:  Mol Immunol       Date:  1993-01       Impact factor: 4.407

9.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

Authors:  M Brüggemann; G T Williams; C I Bindon; M R Clark; M R Walker; R Jefferis; H Waldmann; M S Neuberger
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.

Authors:  C I Bindon; G Hale; M Brüggemann; H Waldmann
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  16 in total

1.  Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.

Authors:  James T Heads; Ralph Adams; Lena E D'Hooghe; Matt J T Page; David P Humphreys; Andrew G Popplewell; Alastair D Lawson; Alistair J Henry
Journal:  Protein Sci       Date:  2012-08-09       Impact factor: 6.725

2.  Evidence of disulfide bond scrambling during production of an antibody-drug conjugate.

Authors:  Lily Pei-Yao Liu-Shin; Adam Fung; Arun Malhotra; Gayathri Ratnaswamy
Journal:  MAbs       Date:  2018-10-19       Impact factor: 5.857

3.  The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.

Authors:  John-Paul Silva; Olivia Vetterlein; Joby Jose; Shirley Peters; Hishani Kirby
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

4.  Monovalent IgG4 molecules: immunoglobulin Fc mutations that result in a monomeric structure.

Authors:  Ian C Wilkinson; Susan B Fowler; Leeann Machiesky; Kenneth Miller; David B Hayes; Morshed Adib; Cheng Her; M Jack Borrok; Ping Tsui; Matthew Burrell; Dominic J Corkill; Susanne Witt; David C Lowe; Carl I Webster
Journal:  MAbs       Date:  2013-04-08       Impact factor: 5.857

5.  L445P mutation on heavy chain stabilizes IgG4 under acidic conditions.

Authors:  Chang-Ai Xu; Andrew Z Feng; Charan K Ramineni; Matthew R Wallace; Elizabeth K Culyba; Kevin P Guay; Kinjal Mehta; Robert Mabry; Stephen Farrand; Jin Xu; Jianwen Feng
Journal:  MAbs       Date:  2019-07-11       Impact factor: 5.857

Review 6.  Effects of localized interactions and surface properties on stability of protein-based therapeutics.

Authors:  Brittney J Mills; Jennifer S Laurence Chadwick
Journal:  J Pharm Pharmacol       Date:  2016-11-10       Impact factor: 3.765

7.  Site-targeted mutagenesis for stabilization of recombinant monoclonal antibody expressed in tobacco (Nicotiana tabacum) plants.

Authors:  Verena K Hehle; Matthew J Paul; Victoria A Roberts; Craig J van Dolleweerd; Julian K-C Ma
Journal:  FASEB J       Date:  2015-12-28       Impact factor: 5.191

8.  Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activity.

Authors:  Zenjiro Sampei; Tomoyuki Igawa; Tetsuhiro Soeda; Miho Funaki; Kazutaka Yoshihashi; Takehisa Kitazawa; Atsushi Muto; Tetsuo Kojima; Satoshi Nakamura; Kunihiro Hattori
Journal:  MAbs       Date:  2015       Impact factor: 5.857

9.  A comprehensive analysis of novel disulfide bond introduction site into the constant domain of human Fab.

Authors:  Hitomi Nakamura; Moeka Yoshikawa; Naoko Oda-Ueda; Tadashi Ueda; Takatoshi Ohkuri
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

10.  Experimental and in silico modelling analyses of the gene expression pathway for recombinant antibody and by-product production in NS0 cell lines.

Authors:  Emma J Mead; Lesley M Chiverton; Sarah K Spurgeon; Elaine B Martin; Gary A Montague; C Mark Smales; Tobias von der Haar
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.